1526 related articles for article (PubMed ID: 28448266)
1. A Prospective, Randomized, Blinded, Controlled Trial Comparing Transdermal Continuous Oxygen Delivery to Moist Wound Therapy for the Treatment of Diabetic Foot Ulcers.
Driver VR; Reyzelman A; Kawalec J; French M
Ostomy Wound Manage; 2017 Apr; 63(4):12-28. PubMed ID: 28448266
[TBL] [Abstract][Full Text] [Related]
2. Poorly designed research does not help clarify the role of hyperbaric oxygen in the treatment of chronic diabetic foot ulcers.
Mutluoglu M; Uzun G; Bennett M; Germonpré P; Smart D; Mathieu D
Diving Hyperb Med; 2016 Sep; 46(3):133-134. PubMed ID: 27723012
[TBL] [Abstract][Full Text] [Related]
3. A prospective, randomized clinical study evaluating the effect of transdermal continuous oxygen therapy on biological processes and foot ulcer healing in persons with diabetes mellitus.
Driver VR; Yao M; Kantarci A; Gu G; Park N; Hasturk H
Ostomy Wound Manage; 2013 Nov; 59(11):19-26. PubMed ID: 24201169
[TBL] [Abstract][Full Text] [Related]
4. A multicentre prospective randomised controlled comparative parallel study of dehydrated human umbilical cord (EpiCord) allograft for the treatment of diabetic foot ulcers.
Tettelbach W; Cazzell S; Sigal F; Caporusso JM; Agnew PS; Hanft J; Dove C
Int Wound J; 2019 Feb; 16(1):122-130. PubMed ID: 30246926
[TBL] [Abstract][Full Text] [Related]
5. Continuous diffusion of oxygen improves diabetic foot ulcer healing when compared with a placebo control: a randomised, double-blind, multicentre study.
Niederauer MQ; Michalek JE; Liu Q; Papas KK; Lavery LA; Armstrong DG
J Wound Care; 2018 Sep; 27(Sup9):S30-S45. PubMed ID: 30207844
[TBL] [Abstract][Full Text] [Related]
6. Topical wound oxygen therapy in the treatment of severe diabetic foot ulcers: a prospective controlled study.
Blackman E; Moore C; Hyatt J; Railton R; Frye C
Ostomy Wound Manage; 2010 Jun; 56(6):24-31. PubMed ID: 20567051
[TBL] [Abstract][Full Text] [Related]
7. A Prospective, Randomized, Double-Blind Multicenter Study Comparing Continuous Diffusion of Oxygen Therapy to Sham Therapy in the Treatment of Diabetic Foot Ulcers.
Niederauer MQ; Michalek JE; Armstrong DG
J Diabetes Sci Technol; 2017 Sep; 11(5):883-891. PubMed ID: 28654304
[TBL] [Abstract][Full Text] [Related]
8. A Prospective, Descriptive Study to Assess the Clinical Benefits of Using Calendula officinalis Hydroglycolic Extract for the Topical Treatment of Diabetic Foot Ulcers.
Buzzi M; de Freitas F; Winter M
Ostomy Wound Manage; 2016 Mar; 62(3):8-24. PubMed ID: 26978856
[TBL] [Abstract][Full Text] [Related]
9. Ultrasound therapy for recalcitrant diabetic foot ulcers: results of a randomized, double-blind, controlled, multicenter study.
Ennis WJ; Foremann P; Mozen N; Massey J; Conner-Kerr T; Meneses P
Ostomy Wound Manage; 2005 Aug; 51(8):24-39. PubMed ID: 16234574
[TBL] [Abstract][Full Text] [Related]
10. Evaluation of Wound Closure Rates Using a Human Fibroblast-derived Dermal Substitute Versus a Fetal Bovine Collagen Dressing: A Retrospective Study.
Fitzgerald RH; Sabolinski ML; Skornicki M
Wound Manag Prev; 2019 Sep; 65(9):26-34. PubMed ID: 31702990
[TBL] [Abstract][Full Text] [Related]
11. Systematic reviews of wound care management: (3) antimicrobial agents for chronic wounds; (4) diabetic foot ulceration.
O'Meara S; Cullum N; Majid M; Sheldon T
Health Technol Assess; 2000; 4(21):1-237. PubMed ID: 11074391
[TBL] [Abstract][Full Text] [Related]
12. Comparison of negative pressure wound therapy using vacuum-assisted closure with advanced moist wound therapy in the treatment of diabetic foot ulcers: a multicenter randomized controlled trial.
Blume PA; Walters J; Payne W; Ayala J; Lantis J
Diabetes Care; 2008 Apr; 31(4):631-6. PubMed ID: 18162494
[TBL] [Abstract][Full Text] [Related]
13. A prospective, multicenter, randomized, controlled clinical trial comparing a bioengineered skin substitute to a human skin allograft.
Sanders L; Landsman AS; Landsman A; Keller N; Cook J; Cook E; Hopson M
Ostomy Wound Manage; 2014 Sep; 60(9):26-38. PubMed ID: 25211605
[TBL] [Abstract][Full Text] [Related]
14. Topical oxygen treatment relieves pain from hard-to-heal leg ulcers and improves healing: a case report.
Palin L; Nordgren M; Lingemark A; Jebril W; Wikstrom JD
J Wound Care; 2021 Mar; 30(3):210-212. PubMed ID: 33729843
[TBL] [Abstract][Full Text] [Related]
15. Safety and Efficacy of an Autologous Blood Clot Product in the Management of Texas 1A or 2A Neuropathic Diabetic Foot Ulcers: A Prospective, Multicenter, Open Label Pilot Study.
Snyder RJ; Kasper MA; Patel K; Carter MJ; Kushnir I; Kushnir A; Serena TE
Wounds; 2018 Jul; 30(7):84-89. PubMed ID: 29718812
[TBL] [Abstract][Full Text] [Related]
16. Effect of noncontact normothermic wound therapy on the healing of neuropathic (diabetic) foot ulcers: an interim analysis of 20 patients.
Alvarez OM; Rogers RS; Booker JG; Patel M
J Foot Ankle Surg; 2003; 42(1):30-5. PubMed ID: 12567365
[TBL] [Abstract][Full Text] [Related]
17. A Prospective, Randomized, Multicenter, Controlled Evaluation of the Use of Dehydrated Amniotic Membrane Allograft Compared to Standard of Care for the Closure of Chronic Diabetic Foot Ulcer.
Snyder RJ; Shimozaki K; Tallis A; Kerzner M; Reyzelman A; Lintzeris D; Bell D; Rutan RL; Rosenblum B
Wounds; 2016 Mar; 28(3):70-7. PubMed ID: 26978860
[TBL] [Abstract][Full Text] [Related]
18. Wound closure in patients with DFU: a cost-effectiveness analysis of two cellular/tissue-derived products.
Gilligan AM; Waycaster CR; Landsman AL
J Wound Care; 2015 Mar; 24(3):149-56. PubMed ID: 25764960
[TBL] [Abstract][Full Text] [Related]
19. A randomized, controlled trial of Promogran (a collagen/oxidized regenerated cellulose dressing) vs standard treatment in the management of diabetic foot ulcers.
Veves A; Sheehan P; Pham HT
Arch Surg; 2002 Jul; 137(7):822-7. PubMed ID: 12093340
[TBL] [Abstract][Full Text] [Related]
20. Apligraf in the treatment of neuropathic diabetic foot ulcers.
Edmonds M;
Int J Low Extrem Wounds; 2009 Mar; 8(1):11-8. PubMed ID: 19189997
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
